Quarter ended 30 September 2026: consolidated revenue up 13%, profit after tax down 55% year on year
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended 30 September 2026: revenue from operations Rs 73,016 lakh versus Rs 64,516 lakh year earlier; profit after tax Rs 925 lakh versus Rs 2,066 lakh. A Rs 1,159 lakh customs duty and interest provision was booked as an exceptional charge. Six-month consolidated: revenue Rs 142,355 lakh versus Rs 125,696 lakh; profit after tax Rs 2,571 lakh versus Rs 2,664 lakh. BACC was sold to a related party for Rs 3,764 lakh in June.
Revenue rose 13%, but an exceptional customs charge caused a 55% profit after tax fall; six-month profit was nearly flat, so outlook is mixed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹731.8 Cr | ₹646.9 Cr | +13.1% |
| Operating profit | ₹27.17 Cr | ₹16.89 Cr | +60.9% |
| Profit after tax | ₹9.25 Cr | ₹20.66 Cr | −55.2% |
| EBITDA margin | 16.6% | 19.1% | −2.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.